These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 34942646)

  • 1. Corrigendum to: A functional CNVR_3425.1 damping lincRNA FENDRR increases lifetime risk of lung cancer and COPD in Chinese.
    Yang L; Wu D; Chen J; Chen J; Qiu F; Li Y; Liu L; Cao Y; Yang B; Zhou Y; Lu J
    Carcinogenesis; 2021 Dec; 42(12):1506-1507. PubMed ID: 34942646
    [No Abstract]   [Full Text] [Related]  

  • 2. A functional CNVR_3425.1 damping lincRNA FENDRR increases lifetime risk of lung cancer and COPD in Chinese.
    Yang L; Wu D; Chen J; Chen J; Qiu F; Li Y; Liu L; Cao Y; Yang B; Zhou Y; Lu J
    Carcinogenesis; 2018 Mar; 39(3):347-359. PubMed ID: 29293945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bioinformatics Analysis of DNA Methylation in the Promoters of LincRNA 
in Lung Adenocarcinoma].
    Zhang W; Li S; Guo N; Zhao Y
    Zhongguo Fei Ai Za Zhi; 2018 Jun; 21(6):470-475. PubMed ID: 29945706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased FENDRR and LincRNA-p21 expression in atherosclerotic plaque.
    Çekin N; Özcan A; Göksel S; Arslan S; Pınarbaşı E; Berkan Ö
    Anatol J Cardiol; 2018 Feb; 19(2):131-136. PubMed ID: 29424733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA FENDRR attenuates the stemness of non-small cell lung cancer cells via decreasing multidrug resistance gene 1 (MDR1) expression through competitively binding with RNA binding protein HuR.
    Gong F; Dong D; Zhang T; Xu W
    Eur J Pharmacol; 2019 Jun; 853():345-352. PubMed ID: 30981768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Therapeutic Value and Molecular Mechanisms of lncRNA FENDRR in Human Cancer.
    Xu W; Wang B; Cai Y; Chen J; Meng E; Guo C; Zhou G; Yuan C
    Curr Pharm Des; 2021; 27(39):4100-4106. PubMed ID: 34414867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long Noncoding RNA
    Senavirathna LK; Liang Y; Huang C; Yang X; Bamunuarachchi G; Xu D; Dang Q; Sivasami P; Vaddadi K; Munteanu MC; Hewawasam S; Cheresh P; Kamp DW; Liu L
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA FENDRR suppresses the progression of NSCLC via regulating miR-761/TIMP2 axis.
    Zhang G; Wang Q; Zhang X; Ding Z; Liu R
    Biomed Pharmacother; 2019 Oct; 118():109309. PubMed ID: 31545237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA FENDRR inhibits NSCLC cell growth and aggressiveness by sponging miR-761.
    Zhang MY; Zhang ZL; Cui HX; Wang RK; Fu L
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8324-8332. PubMed ID: 30556873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA FENDRR attenuates colon cancer progression by repression of SOX4 protein.
    Liu J; Du W
    Onco Targets Ther; 2019; 12():4287-4295. PubMed ID: 31213846
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of functional CNV region networks using a CNV-gene mapping algorithm in a genome-wide scale.
    Park C; Ahn J; Yoon Y; Park S
    Bioinformatics; 2012 Aug; 28(15):2045-51. PubMed ID: 22652832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased expression of the long non-coding RNA FENDRR is associated with poor prognosis in gastric cancer and FENDRR regulates gastric cancer cell metastasis by affecting fibronectin1 expression.
    Xu TP; Huang MD; Xia R; Liu XX; Sun M; Yin L; Chen WM; Han L; Zhang EB; Kong R; De W; Shu YQ
    J Hematol Oncol; 2014 Aug; 7():63. PubMed ID: 25167886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The FENDRR/miR-214-3P/TET2 axis affects cell malignant activity via RASSF1A methylation in gastric cancer.
    He Z; Wang X; Huang C; Gao Y; Yang C; Zeng P; Chen Z
    Am J Transl Res; 2018; 10(10):3211-3223. PubMed ID: 30416662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The FENDRR/FOXC2 Axis Contributes to Multidrug Resistance in Gastric Cancer and Correlates With Poor Prognosis.
    Liu H; Zhang Z; Han Y; Fan A; Liu H; Zhang X; Liu Y; Zhang R; Liu W; Lu Y; Fan D; Zhao X; Nie Y
    Front Oncol; 2021; 11():634579. PubMed ID: 33869020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FENDRR Sponges miR-424-5p to Inhibit Cell Proliferation, Migration and Invasion in Colorectal Cancer.
    Cheng C; Li H; Zheng J; Xu J; Gao P; Wang J
    Technol Cancer Res Treat; 2020; 19():1533033820980102. PubMed ID: 33356998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FENDRR: A pivotal, cancer-related, long non-coding RNA.
    Zheng Q; Zhang Q; Yu X; He Y; Guo W
    Biomed Pharmacother; 2021 May; 137():111390. PubMed ID: 33761608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The long non-coding RNA Fendrr links epigenetic control mechanisms to gene regulatory networks in mammalian embryogenesis.
    Grote P; Herrmann BG
    RNA Biol; 2013 Oct; 10(10):1579-85. PubMed ID: 24036695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of long noncoding RNA FENDRR predicts poor prognosis in renal cell carcinoma.
    He W; Zhong G; Wang P; Jiang C; Jiang N; Huang J
    Oncol Lett; 2019 Jan; 17(1):103-112. PubMed ID: 30655744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of splicing MST1R in gastric cancer was enhanced by lncRNA FENDRR.
    Zhou D; Zhu X; Wu X; Zheng J; Tou L; Zhou Y
    Exp Ther Med; 2021 Aug; 22(2):798. PubMed ID: 34093754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA FENDRR reduces prostate cancer malignancy by competitively binding miR-18a-5p with RUNX1.
    Zhang G; Han G; Zhang X; Yu Q; Li Z; Li Z; Li J
    Biomarkers; 2018 Jul; 23(5):435-445. PubMed ID: 29465000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.